Psychodynamic Motivation and Training program (PMT) for the secondary prevention in patients with stable coronary heart disease: study protocol for a randomized controlled trial of feasibility and effects

Matthias Michal, Perikles Simon, Tommaso Gori, Jochem König, Philipp S Wild, Jörg Wiltink, Suzan Tug, Björn Sterzing, Josef Unterrainer, Thomas Münzel, Manfred E Beutel, Matthias Michal, Perikles Simon, Tommaso Gori, Jochem König, Philipp S Wild, Jörg Wiltink, Suzan Tug, Björn Sterzing, Josef Unterrainer, Thomas Münzel, Manfred E Beutel

Abstract

Background: Nonpharmacological secondary prevention of coronary heart disease is considered a safe and effective measure to substantially reduce mortality. Despite the effectiveness of lifestyle changes, the compliance rate of patients is very low mainly due to psychosocial barriers. Psychotherapeutic approaches that address how persons think about themselves and their behaviors appear to have a significant potential for improving health behavior.

Methods/design: Against this background, our study aims to examine the feasibility and effects of a Psychodynamic Motivation and Training program (PMT) as compared to one session of advice in exercise training (EX) and treatment as usual (TAU). For that purpose, 90 patients with stable coronary heart disease and a physically inactive lifestyle will be randomly assigned to the three groups (each with n = 30). The primary outcome is the change in the individual anaerobic threshold as determined by spiroergometry from baseline to six month follow-up. Secondary endpoints include change in endothelial function, biomarkers of inflammation and oxidative stress, quality of life, symptoms of fatigue, illness perception and feasibility of the treatment approach. We hypothesize that physical fitness will improve more in PMT than in EX and TAU, with PMT and EX more than TAU, and that the effects will be more pronounced for participants with current mental or psychosocial distress.

Discussion: The results of the study will help to determine the effectiveness of a psychodynamic lifestyle change approach and to identify measures for designing specifically tailored interventions to improve compliance with cardiovascular prevention.

Trial registration: ClinicalTrials.gov Identifier: NCT01445808.

Figures

Figure 1
Figure 1
Study design.

References

    1. Perk J, De Backer G, Gohlke H, Graham I, Reiner Ž, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur Heart J. 2012;33(13):1635–1701.
    1. Hamer M. Psychosocial stress and cardiovascular disease risk: the role of physical activity. Psychosom Med. 2012;74(9):896–903. doi: 10.1097/PSY.0b013e31827457f4.
    1. Blumenthal JA, Sherwood A, Babyak MA, Watkins LL, Smith PJ, Hoffman BM, O’Hayer CV, Mabe S, Johnson J, Doraiswamy PM. et al.Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol. 2012;60(12):1053–1063. doi: 10.1016/j.jacc.2012.04.040.
    1. Blumenthal JA, Babyak MA, O’Connor C, Keteyian S, Landzberg J, Howlett J, Kraus W, Gottlieb S, Blackburn G, Swank A. et al.Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA. 2012;308(5):465–474. doi: 10.1001/jama.2012.8720.
    1. Smedt DD, Clays E, Annemans L, Boudrez H, Sutter JD, Doyle F, Jennings C, Kotseva K, Pajak A, Pardaens S, The association between self-reported lifestyle changes and health-related quality of life in coronary patients: the EUROASPIRE III survey. Eur J Prev Cardiol. 2013. in press; doi:10.1177/2047487312473846.
    1. Teo K, Lear S, Islam S, Mony P, Dehghan M, Li W, Rosengren A, Lopez-Jaramillo P, Diaz R, Oliveira G. et al.Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study. JAMA. 2013;309(15):1613–1621. doi: 10.1001/jama.2013.3519.
    1. Muller-Riemenschneider F, Damm K, Meinhard C, Bockelbrink A, Vauth C, Willich SN, Greiner W. Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease. GMS Health Technol Assess. 2009;5:Doc16.
    1. Müller-Riemenschneider F, Damm K, Meinard C, Bockelbrink A, Vauth C, Willich S, Greiner G. Nichtmedikamentöse Sekundärprävention der koronaren Herzkrankheit (KHK) Vol. 95. Köln: DIMDI: Schriftenreihe Health Technology Assessment, Bd; 2009.
    1. Rogerson MC, Murphy BM, Bird S, Morris T. “I don’t have the heart”: a qualitative study of barriers to and facilitators of physical activity for people with coronary heart disease and depressive symptoms. Int J Behav Nutr Phys Act. 2012;9:140. doi: 10.1186/1479-5868-9-140.
    1. Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, Kumanyika S, Kraus WE, Fleg JL, Redeker NS. et al.Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(4):406–441. doi: 10.1161/CIR.0b013e3181e8edf1.
    1. Norcross JC. Psychotherapy relationships that work: Therapist contributions and responsiveness to patients. USA: Oxford University Press; 2002.
    1. Petti S. Lifestyle risk factors for oral cancer. Oral Oncol. 2009;45(4–5):340–350.
    1. Eberth B, Olajide D, Craig P, Ludbrook A. Smoking-related disease risk, area deprivation and health behaviors. J Public Health (Oxf) 2013. in press; doi:10.1093/pubmed/fdt031.
    1. Stringhini S, Tabak AG, Akbaraly TN, Sabia S, Shipley MJ, Marmot MG, Brunner EJ, Batty GD, Bovet P, Kivimaki M. Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ. 2012;345:e5452. doi: 10.1136/bmj.e5452.
    1. Michal M, Wiltink J, Reiner I, Kirschner Y, Wild PS, Schulz A, Zwiener I, Blettner M, Beutel ME. Association of mental distress with smoking status in the community: results from the Gutenberg Health Study. J Affect Disord. 2012;146(3):355–360.
    1. Bauman AE, Reis RS, Sallis JF, Wells JC, Loos RJ, Martin BW. Correlates of physical activity: why are some people physically active and others not? Lancet. 2012;380(9838):258–271. doi: 10.1016/S0140-6736(12)60735-1.
    1. Whooley MA, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney RM, Ali S, Dowray S, Na B, Feldman MD. et al.Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300(20):2379–2388. doi: 10.1001/jama.2008.711.
    1. Ye S, Muntner P, Shimbo D, Judd SE, Richman J, Davidson KW, Safford MM. Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease: the REGARDS (Reason for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol. 2013;61(6):622–630. doi: 10.1016/j.jacc.2012.09.058.
    1. Berk M, Sarris J, Coulson CE, Jacka FN. Lifestyle management of unipolar depression. Acta Psychiatr Scand Suppl. 2013;443:38–54.
    1. Blumenthal JA. Targeting lifestyle change in patients with depression. J Am Coll Cardiol. 2013;61(6):631–634. doi: 10.1016/j.jacc.2012.11.029.
    1. Albus C, Beutel ME, Deter HC, Fritzsche K, Hellmich M, Jordan J, Juenger J, Krauth C, Ladwig KH, Michal M. et al.A stepwise psychotherapy intervention for reducing risk in coronary artery disease (SPIRR-CAD) - rationale and design of a multicenter, randomized trial in depressed patients with CAD. J Psychosom Res. 2011;71(4):215–222. doi: 10.1016/j.jpsychores.2011.02.013.
    1. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9):1081–1093.
    1. Heidenreich T, Tuin I, Pflug B, Michal M, Michalak J. Mindfulness-based cognitive therapy for persistent insomnia: a pilot study. Psychother Psychosom. 2006;75(3):188–189. doi: 10.1159/000091778.
    1. McCullough L, Kuhn N, Andrews S. Treating Affect Phobia: A Manual for Short-Term Dynamic Psychotherapy: A Manual for Short-term Dynamic Psychotherapy. New York: Guilford Pubn; 2003.
    1. Katon W, Lin EH, Von Korff M, Ciechanowski P, Ludman E, Young B, Rutter C, Oliver M, McGregor M. Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study. Contemp Clin Trials. 2010;31(4):312–322. doi: 10.1016/j.cct.2010.03.009.
    1. Dickhuth HH, Yin L, Niess A, Rocker K, Mayer F, Heitkamp HC, Horstmann T. Ventilatory, lactate-derived and catecholamine thresholds during incremental treadmill running: relationship and reproducibility. Int J Sports Med. 1999;20(2):122–127.
    1. Roecker K, Striegel H, Dickhuth HH. Heart-rate recommendations: transfer between running and cycling exercise? Int J Sports Med. 2003;24(3):173–178. doi: 10.1055/s-2003-39087.
    1. Wasserman K, Hansen JE, Sue DY, Whipp BJ, Froelicher VF. Principles of exercise testing and interpretation. J Cardiopulm Rehabil Prev. 1987;7(4):189. doi: 10.1097/00008483-198704000-00014.
    1. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 1986;60(6):2020–2027.
    1. Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease: functional markers. Circulation. 2004;109(25 Suppl 1):IV31–IV46.
    1. Gori T, Muxel S, Damaske A, Radmacher MC, Fasola F, Schaefer S, Schulz A, Jabs A, Parker JD, Munzel T. Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease. Eur Heart J. 2012;33(3):363–371. doi: 10.1093/eurheartj/ehr361.
    1. Gori T, Dragoni S, Lisi M, Di Stolfo G, Sonnati S, Fineschi M, Parker JD. Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol. 2008;51(20):1953–1958. doi: 10.1016/j.jacc.2008.01.049.
    1. Bartoli G, Menegaz G, Lisi M, Di Stolfo G, Dragoni S, Gori T. Model-based analysis of flow-mediated dilation and intima-media thickness. Int J Biomed Imaging. 2008;2008:738545.
    1. EuroQol. EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol group. Health Policy. 1990;16(3):199–208.
    1. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonnell M, Fihn SD. Development and evaluation of the Seattle Angina questionnaire: a new functional status measure for coronary artery disease* 1. J Am Coll Cardiol. 1995;25(2):333–341. doi: 10.1016/0735-1097(94)00397-9.
    1. Appels A, Hoppener P, Mulder P. A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol. 1987;17(1):15–24. doi: 10.1016/0167-5273(87)90029-5.
    1. Smets E, Garssen B, Bonke B, De Haes J. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–325. doi: 10.1016/0022-3999(94)00125-O.
    1. Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research* 1. J Clin Epidemiol. 1988;41(4):313–321. doi: 10.1016/0895-4356(88)90138-2.
    1. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–637. doi: 10.1016/j.jpsychores.2005.10.020.
    1. Petrie KJ, Cameron LD, Ellis CJ, Buick D, Weinman J. Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med. 2002;64(4):580–586.
    1. Baecke J, Burema J, Frijters J. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936–942.
    1. Spitzer RL, Williams JB, Kroenke K, Linzer M, DeGruy FV 3rd, Hahn SR, Brody D, Johnson JG. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272(22):1749–1756. doi: 10.1001/jama.1994.03520220043029.
    1. Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord. 2004;78(2):131–140. doi: 10.1016/S0165-0327(02)00237-9.
    1. Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–325. doi: 10.7326/0003-4819-146-5-200703060-00004.
    1. Kroenke K, Spitzer RL, Williams JB, Lowe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–359. doi: 10.1016/j.genhosppsych.2010.03.006.
    1. MacGregor KL, Funderburk JS, Pigeon W, Maisto SA. Evaluation of the PHQ-9 Item 3 as a screen for sleep disturbance in primary care. J Gen Intern Med. 2012;27(3):339–344. doi: 10.1007/s11606-011-1884-5.
    1. Lowe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brahler E. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1–2):86–95.
    1. Skapinakis P. The 2-item generalized anxiety disorder scale had high sensitivity and specificity for detecting GAD in primary care. Evid Based Med. 2007;12(5):149. doi: 10.1136/ebm.12.5.149.
    1. Pedersen SS, Denollet J, de Jonge P, Simsek C, Serruys PW, van Domburg RT. Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting. J Gen Intern Med. 2009;24(9):1037–1042. doi: 10.1007/s11606-009-1054-1.
    1. Kaller CP JMU, Kaiser S, Weisbrod M. Tower of London - Freiburger Version. Mödling: Schuhfried; 2011.
    1. Kaller CP, Rahm B, Kostering L, Unterrainer JM. Reviewing the impact of problem structure on planning: a software tool for analyzing tower tasks. Behav Brain Res. 2011;216(1):1–8. doi: 10.1016/j.bbr.2010.07.029.
    1. Keith Berg W, Byrd D. The tower of London spatial problem-solving task: enhancing clinical and research implementation. J Clin Exp Neuropsychol. 2002;24(5):586–604. doi: 10.1076/jcen.24.5.586.1006.
    1. Kaller CP, Unterrainer JM, Stahl C. Assessing planning ability with the tower of London task: psychometric properties of a structurally balanced problem set. Psychol Assess. 2012;24(1):46–53.
    1. Chang YK, Ku PW, Tomporowski PD, Chen FT, Huang CC. Effects of acute resistance exercise on late-middle-age adults’ goal planning. Med Sci Sports Exerc. 2012;44(9):1773–1779. doi: 10.1249/MSS.0b013e3182574e0b.
    1. Chang YK, Chu IH, Chen FT, Wang CC. Dose–response effect of acute resistance exercise on tower of London in middle-aged adults. J Sport Exerc Psychol. 2011;33(6):866–883.
    1. Fortini A, Bonechi F, Taddei T, Gensini GF, Malfanti PL, Neri Serneri GG. Anaerobic threshold in patients with exercise-induced myocardial ischemia. Circulation. 1991;83(5 Suppl):III50–III53.
    1. Gitt AK, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M, Schneider S, Schwarz A, Senges J. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation. 2002;106(24):3079–3084. doi: 10.1161/01.CIR.0000041428.99427.06.
    1. Corra U, Mezzani A, Bosimini E, Scapellato F, Imparato A, Giannuzzi P. Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J. 2002;143(3):418–426. doi: 10.1067/mhj.2002.120772.
    1. Faude O, Kindermann W, Meyer T. Lactate threshold concepts: how valid are they? Sports Med. 2009;39(6):469–490. doi: 10.2165/00007256-200939060-00003.
    1. Myers J, Hadley D, Oswald U, Bruner K, Kottman W, Hsu L, Dubach P. Effects of exercise training on heart rate recovery in patients with chronic heart failure. Am Heart J. 2007;153(6):1056–1063. doi: 10.1016/j.ahj.2007.02.038.
    1. Valkeinen H, Aaltonen S, Kujala UM. Effects of exercise training on oxygen uptake in coronary heart disease: a systematic review and meta-analysis. Scand J Med Sci Sports. 2010;20(4):545–555. doi: 10.1111/j.1600-0838.2010.01133.x.
    1. Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, Fiore C, Harlow LL, Redding CA, Rosenbloom D. et al.Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13(1):39–46.
    1. Norcross JC, Krebs PM, Prochaska JO. Stages of change. J Clin Psychol. 2011;67(2):143–154. doi: 10.1002/jclp.20758.
    1. Montero D, Walther G, Benamo E, Perez-Martin A, Vinet A. Effects of Exercise Training on Arterial Function in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Sports Med. 2013. pp. 1–9. doi: 10.1007/s40279-013-0085-2.
    1. Spence AL, Carter HH, Naylor LH, Green DJ. A prospective randomized longitudinal study involving 6 months of endurance or resistance exercise. conduit artery adaptation in humans. J Physiol. 2013;591(Pt 5):1265–1275.
    1. Black MA, Cable NT, Thijssen DH, Green DJ. Impact of age, sex, and exercise on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol. 2009;297(3):H1109–H1116. doi: 10.1152/ajpheart.00226.2009.
    1. Franzoni F, Ghiadoni L, Galetta F, Plantinga Y, Lubrano V, Huang Y, Salvetti G, Regoli F, Taddei S, Santoro G. et al.Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens. 2005;18(4 Pt 1):510–516.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir